Applications of tetrahedral DNA nanostructures in wound repair and tissue regeneration

Abstract

Tetrahedral DNA nanostructures (TDNs) are molecules with a pyramidal structure formed by folding four single strands of DNA based on the principle of base pairing. Although DNA has polyanionic properties, the special spatial structure of TDNs allows them to penetrate the cell membrane without the aid of transfection agents in a caveolin-dependent manner and enables them to participate in the regulation of cellular processes without obvious toxic side effects. Because of their stable spatial structure, TDNs resist the limitations imposed by nuclease activity and innate immune responses to DNA. In addition, TDNs have good editability and biocompatibility, giving them great advantages for biomedical applications. Previous studies have found that TDNs have a variety of biological properties, including promoting cell migration, proliferation and differentiation, as well as having anti-inflammatory, antioxidant, anti-infective and immune regulation capabilities. Moreover, we confirmed that TDNs can promote the regeneration and repair of skin, blood vessels, muscles and bone tissues. Based on these findings, we believe that TDNs have broad prospects for application in wound repair and regeneration. This article reviews recent progress in TDN research and its applications.

Keywords

Tetrahedral DNA nanostructures / Wound treatment / Injury repair / Injury regeneration / Tissue regeneration

References

[1] Liang L, Li J, Li Q, Huang Q, Shi J, Yan H, et al. Single-Particle Tracking and Modulation of Cell Entry Pathways of a Tetrahedral DNA Nanostructure in Live Cells. Angew Chem Int Ed. 2014; 53: 7745-50.

[2] Zhang M, Zhang X, Tian T, Zhang Q, Wen Y, Zhu J, et al. Anti-inflammatory activity of curcumin-loaded tetrahedral framework nucleic acids on acute gouty arthritis. Bioactive materials. 2022; 8: 368-80.

[3] Hu Y, Cecconello A, Idili A, Ricci F, Willner I. Triplex DNA Nanostructures: From Basic Properties to Applications. Angew Chem Int Ed. 2017; 56: 15210-33.

[4] Zhang Q, Lin S, Wang L, Peng S, Lin Y. Tetrahedral framework nucleic acids act as antioxidants in acute kidney injury treatment. Chem Eng J. 2020; 127426.

[5] Goodman RP, Schaap IA, Tardin CF, Erben CM, Berry RM, Schmidt CF, et al. Rapid chiral assembly of rigid DNA building blocks for molecular nanofabrication. Science (New York, NY). 2005; 310: 1661-5.

[6] Chen J, Seeman N. Synthesis from DNA of a molecule with the connectivity of a cube. Nature. 1991; 350: 631-3.

[7] Walsh AS, Yin H, Erben CM, Wood MJ, Turberfield AJ. DNA cage delivery to mammalian cells. ACS Nano. 2011; 5: 5427-32.

[8] Zhang Y, Seeman NC. Construction of a DNA-Truncated Octahedron. J Am Chem Soc. 1994; 116: 1661-9.

[9] Shih W, Quispe J, Joyce G. A 1.7-kilobase single-stranded DNA that folds into a nanoscale octahedron. Nature. 2004; 427: 618-21.

[10] Vindigni G, Raniolo S, Ottaviani A, Falconi M, Franch O, Knudsen B, et al. Receptor-Mediated Entry of Pristine Octahedral DNA Nanocages in Mammalian Cells. ACS Nano. 2016; 10: 5971-9.

[11] Zagorovsky K, Chou L, Chan W. Controlling DNA-nanoparticle serum interactions. Proc Natl Acad Sci U S A. 2016; 113: 13600-5.

[12] Li J, Pei H, Zhu B, Liang L, Wei M, He Y, et al. Self-assembled multivalent DNA nanostructures for noninvasive intracellular delivery of immunostimulatory CpG oligonucleotides. ACS Nano. 2011; 5: 8783-9.

[13] Conway J, McLaughlin C, Castor K, Sleiman H. DNA nanostructure serum stability: greater than the sum of its parts. Chem Commun (Camb). 2013; 49: 1172-4.

[14] Cortez M, Godbey W, Fang Y, Payne M, Cafferty B, Kosakowska K, et al. The Synthesis of Cyclic Poly(ethylene imine) and Exact Linear Analogues: An Evaluation of Gene Delivery Comparing Polymer Architectures. J Am Chem Soc. 2015; 137: 6541-9.

[15] Pei H, Zuo X, Zhu D, Huang Q, Fan C. Functional DNA Nanostructures for Theranostic Applications. Acc Chem Res. 2014; 47: 550-9.

[16] Xianyu Y, Wang Z, Jiang X. A plasmonic nanosensor for immunoassay via enzyme-triggered click chemistry. ACS Nano. 2014; 8: 12741-7.

[17] Rothemund PW. Folding DNA to create nanoscale shapes and patterns. Nature. 2006; 440: 297-302.

[18] Um S, Lee J, Park N, Kwon S, Umbach C, Luo D. Enzyme-catalysed assembly of DNA hydrogel. Nat Mater. 2006; 5: 797-801.

[19] Douglas S, Dietz H, Liedl T, Högberg B, Graf F, Shih W. Self-assembly of DNA into nanoscale three-dimensional shapes. Nature. 2009; 459: 414-8.

[20] Kearney C, Lucas C, O’Brien F, Castro C. DNA Origami: Folded DNA-Nanodevices That Can Direct and Interpret Cell Behavior. Advanced materials (Deerfield Beach, Fla). 2016; 28: 5509-24.

[21] Qu X, Zhu D, Yao G, Su S, Chao J, Liu H, et al. An Exonuclease III-Powered, On-Particle Stochastic DNA Walker. Angewandte Chemie (International ed in English). 2017; 56: 1855-8.

[22] Ho J, Walsh C, Yue D, Dardik A, Cheema U. Current Advancements and Strategies in Tissue Engineering for Wound Healing: A Comprehensive Review. Adv Wound Care (New Rochelle). 2017; 6: 191-209.

[23] Zhou L, Gjvm VO, Malda J, Stoddart MJ, Lai Y, Richards RG, et al. Innovative Tissue-Engineered Strategies for Osteochondral Defect Repair and Regeneration: Current Progress and Challenges. Adv Healthc Mater. 2020; e2001008.

[24] Dhingra GA, Kaur M, Singh M, Aggarwal G, Nagpal M. Lock Stock and Barrel of Wound Healing. Curr Pharm Des. 2019; 25: 4090-107.

[25] Bai Q, Han K, Dong K, Zheng C, Zhang Y, Long Q, et al. Potential Applications of Nanomaterials and Technology for Diabetic Wound Healing. Int J Nanomedicine. 2020; 15: 9717-43.

[26] Nourian Dehkordi A, Mirahmadi Babaheydari F, Chehelgerdi M, Raeisi DS. Skin tissue engineering: wound healing based on stem-cell-based therapeutic strategies. Stem Cell Res Ther. 2019; 10: 111.

[27] Weng T, Wu P, Zhang W, Zheng Y, Li Q, Jin R, et al. Regeneration of skin appendages and nerves: current status and further challenges. J Transl Med. 2020; 18: 53.

[28] Zhang T, Cui W, Tian T, Shi S, Lin Y. Progress in Biomedical Applications of Tetrahedral Framework Nucleic Acid-Based Functional Systems. ACS Appl Mater Interfaces. 2020; 12: 47115-26.

[29] Zhang T, Tian T, Lin Y. Functionalizing Framework Nucleic Acid-Based Nanostructures for Biomedical Application. Adv Mater. 2021: e2107820. 10.1002/adma.202107820.

[30] Churchill M, Tullius T, Kallenbach N, Seeman N. A Holliday recombination intermediate is twofold symmetric. Proc Natl Acad Sci U S A. 1988; 85: 4653-6.

[31] Li J, Xiao L, Yan N, Li Y, Wang Y, Qin X, et al. The Neuroprotective Effect of MicroRNA-22-3p Modified Tetrahedral Framework Nucleic Acids on Damaged Retinal Neurons Via TrkB/BDNF Signaling Pathway. Adv Funct Mater. 2021; 31: 2104141.

[32] Tian T, Xiao D, Zhang T, Li Y, Shi S, Zhong W, et al. A Framework Nucleic Acid Based Robotic Nanobee for Active Targeting Therapy. Adv Funct Mater. 2021; 31: 2007342.

[33] Sun Y, Liu Y, Zhang B, Shi S, Zhang T, Zhao D, et al. Escherichia coli (E. coli) Erythromycin loaded by tetrahedral framework nucleic acids are more antimicrobial sensitive against. Bioactive materials. 2021; 6: 2281-90.

[34] Dong S, Zhao R, Zhu J, Lu X, Li Y, Qiu S, et al. Electrochemical DNA Biosensor Based on a Tetrahedral Nanostructure Probe for the Detection of Avian Influenza A (H7N9) Virus. ACS Appl Mater Interfaces. 2015; 7: 8834-42.

[35] Peng Q, Shao X-R, Xie J, Shi S-R, Wei X-Q, Zhang T, et al. Understanding the Biomedical Effects of the Self-Assembled Tetrahedral DNA Nanostructure on Living Cells. ACS Appl Mater Interfaces. 2016; 8: 12733-9.

[36] Yang Y, Zhu J, Ma W, Zhang W, Xie Y, Chen X, et al. The remyelination effect of DNA framework nucleic acids on demyelinating diseases. Appl Mater Today. 2021; 24: 101098.

[37] Zhang Y, Xie X, Ma W, Zhan Y, Mao C, Shao X, et al. Multi-targeted Antisense Oligonucleotide Delivery by a Framework Nucleic Acid for Inhibiting Biofilm Formation and Virulence. Nano-micro letters. 2020; 12: 74.

[38] Liu Y, Sun Y, Li S, Liu M, Qin X, Chen X, et al. Tetrahedral Framework Nucleic Acids Deliver Antimicrobial Peptides with Improved Effects and Less Susceptibility to Bacterial Degradation. Nano Lett. 2020; 20: 3602-10.

[39] Sirong S, Yang C, Taoran T, Songhang L, Shiyu L, Yuxin Z, et al. Effects of tetrahedral framework nucleic acid/wogonin complexes on osteoarthritis. Bone Res. 2020; 8: 6.

[40] Cui W, Yang X, Chen X, Xiao D, Zhu J, Zhang M, et al. Treating LRRK2-Related Parkinson’s Disease by Inhibiting the mTOR Signaling Pathway to Restore Autophagy. Adv Funct Mater. 2021n/a; 2105152.

[41] Fu W, Ma L, Ju Y, Xu J, Li H, Shi S, et al. Therapeutic siCCR2 Loaded by Tetrahedral Framework DNA Nanorobotics in Therapy for Intracranial Hemorrhage. Adv Funct Mater. 2021; 31: 2101435.

[42] Li Y, Gao S, Shi S, Xiao D, Peng S, Gao Y, et al. Tetrahedral Framework Nucleic Acid-Based Delivery of Resveratrol Alleviates Insulin Resistance: From Innate to Adaptive Immunity. Nano-micro letters. 2021; 13: 86.

[43] Zhou M, Gao S, Zhang X, Zhang T, Zhang T, Tian T, et al. The protective effect of tetrahedral framework nucleic acids on periodontium under inflammatory conditions. Bioactive materials. 2021; 6: 1676-88.

[44] Zhou Z, Sohn YS, Nechushtai R, Willner I. DNA Tetrahedra Modules as Versatile Optical Sensing Platforms for Multiplexed Analysis of miRNAs, Endonucleases, and Aptamer-Ligand Complexes. ACS Nano. 2020; 14: 9021-31.

[45] Yan J, Zhan X, Zhang Z, Chen K, Wang M, Sun Y, et al. Tetrahedral DNA nanostructures for effective treatment of cancer: advances and prospects. J Nanobiotechnology. 2021; 19: 412.

[46] Zhang T, Tian T, Zhou R, Li S, Ma W, Zhang Y, et al. Design, fabrication and applications of tetrahedral DNA nanostructure-based multifunctional complexes in drug delivery and biomedical treatment. Nat Protoc. 2020; 15: 2728-57.

[47] Li S, Tian T, Zhang T, Cai X, Lin Y. Advances in biological applications of self-assembled DNA tetrahedral nanostructures. Mater Today. 2019; 24: 57-68.

[48] Li S, Liu Y, Tian T, Zhang T, Lin S, Zhou M, et al. Bioswitchable Delivery of microRNA by Framework Nucleic Acids: Application to Bone Regeneration. Small. 2021; 17: 2104359.

[49] Ponnuswamy N, Bastings M, Nathwani B, Ryu J, Chou L, Vinther M, et al. Oligolysine-based coating protects DNA nanostructures from low-salt denaturation and nuclease degradation. Nat Commun. 2017; 8: 15654.

[50] Naldini L. Gene therapy returns to centre stage. Nature. 2015; 526: 351-60.

[51] Shao X, Lin S, Peng Q, Shi S, Wei X, Zhang T, et al. Tetrahedral DNA Nanostructure: A Potential Promoter for Cartilage Tissue Regeneration via Regulating Chondrocyte Phenotype and Proliferation. Small. 2017; 13.

[52] Yang X, Zhang F, Du HaoY CW, Dou Y, Lin Y, et al. Effect of tetrahedral DNA nanostructures on LPS-induced neuroinflammation in mice. Chin Chem Lett. 2021. 10.1016/j.cclet.2021.10.029.

[53] Zhu J, Zhang M, Gao Y, Qin X, Zhang T, Cui W, et al. Tetrahedral framework nucleic acids promote scarless healing of cutaneous wounds via the AKT-signaling pathway. Signal transduction and targeted therapy. 2020; 5: 120.

[54] Shi S, Lin S, Shao X, Li Q, Tao Z, Lin Y. Modulation of chondrocyte motility by tetrahedral DNA nanostructures. Cell Prolif. 2017; 50.

[55] Shi S, Tian T, Li Y, Xiao D, Zhang T, Gong P, et al. Tetrahedral Framework Nucleic Acid Inhibits Chondrocyte Apoptosis and Oxidative Stress through Activation of Autophagy. ACS Appl Mater Interfaces. 2020; 12: 56782-91.

[56] Zhou M, Liu N, Zhang Q, Tian T, Ma Q, Zhang T, et al. Effect of tetrahedral DNA nanostructures on proliferation and osteogenic differentiation of human periodontal ligament stem cells. Cell Prolif. 2019; 52:e12566.

[57] Zhou M, Liu N, Shi S, Li Y, Zhang Q, Ma Q, et al. Effect of tetrahedral DNA nanostructures on proliferation and osteo/odontogenic differentiation of dental pulp stem cells via activation of the notch signaling pathway. Nanomedicine : nanotechnology, biology, and medicine. 2018; 14: 1227-36.

[58] Lin S, Zhang Q, Zhang T, Shao X, Li Y, Shi S, et al. Tetrahedral DNA Nanomaterial Regulates the Biological Behaviors of Adipose-Derived Stem Cells via DNA Methylation on Dlg3. ACS Appl Mater Interfaces. 2018; 10: 32017-25.

[59] Shi S, Lin S, Li Y, Zhang T, Shao X, Tian T, et al. Effects of tetrahedral DNA nanostructures on autophagy in chondrocytes. Chem Commun. 2018; 54: 1327-30.

[60] Gao Y, Zhang T, Zhu J, Xiao D, Zhang M, Sun Y, et al. Effects of the tetrahedral framework nucleic acids on the skeletal muscle regeneration in vitro and in vivo. Materials Chemistry Frontiers. 2020; 4: 2731-43.

[61] Ma W, Xie X, Shao X, Zhang Y, Mao C, Zhan Y, et al. Tetrahedral DNA nanostructures facilitate neural stem cell migration via activating RHOA/ROCK2 signalling pathway. Cell Prolif. 2018; 51: e12503.

[62] Liu N, Zhang X, Li N, Zhou M, Zhang T, Li S, et al. Tetrahedral Framework Nucleic Acids Promote Corneal Epithelial Wound Healing in Vitro and in Vivo. Small. 2019; 15: e1901907.

[63] Ma W, Shao X, Zhao D, Li Q, Liu M, Zhou T, et al. Self-Assembled Tetrahedral DNA Nanostructures Promote Neural Stem Cell Proliferation and Neuronal Differentiation. ACS Appl Mater Interfaces. 2018; 10: 7892-900.

[64] Shao XR, Lin SY, Peng Q, Shi SR, Li XL, Zhang T, et al. Effect of tetrahedral DNA nanostructures on osteogenic differentiation of mesenchymal stem cells via activation of the Wnt/beta-catenin signaling pathway. Nanomedicine. 2017; 13: 1809-19.

[65] Shi S, Peng Q, Shao X, Xie J, Lin S, Zhang T, et al. Self-Assembled Tetrahedral DNA Nanostructures Promote Adipose-Derived Stem Cell Migration via lncRNA XLOC 010623 and RHOA/ROCK2 Signal Pathway. ACS Appl Mater Interfaces. 2016; 8: 19353-63.

[66] Zhao D, Liu M, Li Q, Zhang X, Xue C, Lin Y, et al. Tetrahedral DNA Nanostructure Promotes Endothelial Cell Proliferation, Migration, and Angiogenesis via Notch Signaling Pathway. ACS Appl Mater Interfaces. 2018; 10: 37911-8.

[67] Zhao D, Liu M, Li J, Xiao D, Peng S, He Q, et al. Angiogenic Aptamer-Modified Tetrahedral Framework Nucleic Acid Promotes Angiogenesis In Vitro and In Vivo. ACS Appl Mater Interfaces. 2021; 13: 29439-49.

[68] Zhao D, Cui W, Liu M, Li J, Sun Y, Shi S, et al. Tetrahedral Framework Nucleic Acid Promotes the Treatment of Bisphosphonate-Related Osteonecrosis of the Jaws by Promoting Angiogenesis and M2 Polarization. ACS Appl Mater Interfaces. 2020; 12: 44508-22.

[69] Lin S, Zhang Q, Li S, Zhang T, Wang L, Qin X, et al. Antioxidative and Angiogenesis-Promoting Effects of Tetrahedral Framework Nucleic Acids in Diabetic Wound Healing with Activation of the Akt/Nrf2/HO-1 Pathway. ACS Appl Mater Interfaces. 2020; 12: 11397-408.

[70] Cui W, Zhan Y, Shao X, Fu W, Xiao D, Zhu J, et al. Neuroprotective and Neurotherapeutic Effects of Tetrahedral Framework Nucleic Acids on Parkinson’s Disease in Vitro. ACS Appl Mater Interfaces. 2019; 11: 32787-97.

[71] Shao X, Ma W, Xie X, Li Q, Lin S, Zhang T, et al. Neuroprotective Effect of Tetrahedral DNA Nanostructures in a Cell Model of Alzheimer’s Disease. ACS Appl Mater Interfaces. 2018; 10: 23682-92.

[72] Zhang M, Zhu J, Qin X, Zhou M, Zhang X, Gao Y, et al. Cardioprotection of Tetrahedral DNA Nanostructures in Myocardial Ischemia-Reperfusion Injury. ACS Appl Mater Interfaces. 2019; 11: 30631-9.

[73] Cui W, Yang X, Chen X, Xiao D, Zhu J, Zhang M, et al. Treating LRRK2-Related Parkinson’s Disease by Inhibiting the mTOR Signaling Pathway to Restore Autophagy. Adv Funct Mater. 2021; 31.

[74] Zhang Q, Lin S, Shi S, Zhang T, Ma Q, Tian T, et al. Anti-inflammatory and Antioxidative Effects of Tetrahedral DNA Nanostructures via the Modulation of Macrophage Responses. ACS Appl Mater Interfaces. 2018; 10: 3421-30.

[75] Qin X, Li N, Zhang M, Lin S, Zhu J, Xiao D, et al. Tetrahedral framework nucleic acids prevent retina ischemia-reperfusion injury from oxidative stress via activating the Akt/Nrf2 pathway. Nanoscale. 2019; 11: 20667-75.

[76] Zhang T, Gao Y, Xiao D, Zhu J, Cai X. Nucleic acid based tetrahedral framework DNA nanostructures for fibrotic diseases therapy. Appl Mater Today. 2020; 20: 100725.

[77] Gao S, Li Y, Xiao D, Zhou M, Cai X, Lin Y. Tetrahedral Framework Nucleic Acids Induce Immune Tolerance and Prevent the Onset of Type 1 Diabetes. Nano Lett. 2021; 21: 4437-46.

[78] Evelhoch SR.Biofilm and Chronic Nonhealing Wound Infections. Surg Clin North Am. 2020; 100: 727-32.

[79] Mihai MM, Preda M, Lungu I, Gestal MC, Popa MI, Holban AM. Nanocoatings for Chronic Wound Repair-Modulation of Microbial Colonization and Biofilm Formation. Int J Mol Sci. 2018; 19.

[80] Zhang Y, Ma W, Zhu Y, Shi S, Li Q, Mao C, et al. Inhibiting Methicillin-Resistant Staphylococcus aureus by Tetrahedral DNA Nanostructure-Enabled Antisense Peptide Nucleic Acid Delivery. Nano Lett. 2018; 18: 5652-9.

[81] Cui W, Chen X, Zhu J, Zhang M, Xiao D, Qin X, et al. Preventive effect of tetrahedral framework nucleic acids on bisphosphonate-related osteonecrosis of the jaw. Nanoscale. 2020; 12: 17196-202.

[82] Shao X, Cui W, Xie X, Ma W, Zhan Y, Lin Y. Treatment of Alzheimer’s disease with framework nucleic acids. Cell Prolif. 2020; 53:e12787.

[83] Liu C, Kao W. Corneal Epithelial Wound Healing. Prog Mol Biol Transl Sci. 2015; 134: 61-71.

[84] Abdel-Naby W, Cole B, Liu A, Liu J, Wan P, Guaiquil V, et al. Silk-Derived Protein Enhances Corneal Epithelial Migration, Adhesion, and Proliferation. Invest Ophthalmol Vis Sci. 2017; 58: 1425-33.

[85] Whitcher J, Srinivasan M, Upadhyay M. Corneal blindness: a global perspective. Bull World Health Organ. 2001; 79: 214-21.

[86] Wang Y, Gao G, Wang Y, Wu Y, Peng Z, Zhou Q. S100A4 Inhibitory effects of gene silencing on alkali burn-induced corneal neovascularization: an in vivo study. Mol Vis. 2017; 23: 286-95.

[87] Shu D, Lovicu F. Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis. Prog Retin Eye Res. 2017; 60: 44-65.

[88] Basu S, Hertsenberg A, Funderburgh M, Burrow M, Mann M, Du Y, et al. Human limbal biopsy-derived stromal stem cells prevent corneal scarring. Sci Transl Med. 2014; 6: 266ra172.

[89] Karamanou K, Perrot G, Maquart F, Brézillon S. Lumican as a multivalent effector in wound healing. Adv Drug Deliv Rev. 2018; 129: 344-51.

[90] Reinke J, Sorg H. Wound repair and regeneration. European surgical research Europaische chirurgische Forschung Recherches chirurgicales europeennes. 2012; 49: 35-43.

[91] Singer A, Clark R. Cutaneous wound healing. N Engl J Med. 1999; 341: 738-46.

[92] Laschke M, Harder Y, Amon M, Martin I, Farhadi J, Ring A, et al. Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng. 2006; 12: 2093-104.

[93] Rouwkema J, Rivron N, van Blitterswijk C. Vascularization in tissue engineering. Trends Biotechnol. 2008; 26: 434-41.

[94] Novosel E, Kleinhans C, Kluger P. Vascularization is the key challenge in tissue engineering. Adv Drug Deliv Rev. 2011; 63: 300-11.

[95] Ostrovidov S, Salehi S, Costantini M, Suthiwanich K, Ebrahimi M, Sadeghian R, et al. 3D Bioprinting in Skeletal Muscle Tissue Engineering. Small (Weinheim an der Bergstrasse, Germany). 2019; 15: e1805530.

[96] Jana S, Levengood S, Zhang M. Anisotropic Materials for Skeletal-Muscle-Tissue Engineering. Advanced materials (Deerfield Beach, Fla). 2016; 28: 10588-612.

[97] García-Prat L, Martínez-Vicente M, Perdiguero E, Ortet L, Rodríguez-Ubreva J, Rebollo E, et al. Autophagy maintains stemness by preventing senescence. Nature. 2016; 529: 37-42.

[98] Zecchini S, Giovarelli M, Perrotta C, Morisi F, Touvier T, Di Renzo I, et al. Autophagy controls neonatal myogenesis by regulating the GH-IGF1 system through a NFE2L2-and DDIT3-mediated mechanism. Autophagy. 2019; 15: 58-77.

[99] Roger V, Go A, Lloyd-Jones D, Adams R, Berry J, Brown T, et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation. 2011; 123: e18-209.

[100] Raedschelders K, Ansley D, Chen D. The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. Pharmacol Ther. 2012; 133: 230-55.

[101] Wu L, Wang R. Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev. 2005; 57: 585-630.

[102] Heusch G, Boengler K, Schulz R. Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection. Basic Res Cardiol. 2010; 105: 151-4.

[103] Heusch G, Gersh B. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J. 2017; 38: 774-84.

[104] Lin Y, Luo E, Chen X, Liu L, Qiao J, Yan Z, et al. Molecular and cellular characterization during chondrogenic differentiation of adipose tissue-derived stromal cells in vitro and cartilage formation in vivo. J Cell Mol Med. 2005; 9: 929-39.

[105] Zuk P, Zhu M, Mizuno H, Huang J, Futrell J, Katz A, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001; 7: 211-28.

[106] Mehrabani M, Najafi M, Kamarul T, Mansouri K, Iranpour M, Nematollahi M, et al. Deferoxamine preconditioning to restore impaired HIF-1α-mediated angiogenic mechanisms in adipose-derived stem cells from STZ-induced type 1 diabetic rats. Cell Prolif. 2015; 48: 532-49.

[107] Tan J, Xu X, Tong Z, Lin J, Yu Q, Lin Y, et al. Decreased osteogenesis of adult mesenchymal stem cells by reactive oxygen species under cyclic stretch: a possible mechanism of age related osteoporosis. Bone research. 2015; 3: 15003.

[108] Gong T, Xie J, Liao J, Zhang T, Lin S, Lin Y. Nanomaterials and bone regeneration. Bone research. 2015; 3: 15029.

[109] Wang Z, Zhang D, Hu Z, Cheng J, Zhuo C, Fang X, et al. MicroRNA-26a-modified adipose-derived stem cells incorporated with a porous hydroxyapatite scaffold improve the repair of bone defects. Mol Med Rep. 2015; 12: 3345-50.

[110] Shao X, Lin S, Peng Q, Shi S, Li X, Zhang T, et al. Effect of tetrahedral DNA nanostructures on osteogenic differentiation of mesenchymal stem cells via activation of the Wnt/β-catenin signaling pathway. Nanomedicine : nanotechnology, biology, and medicine. 2017; 13: 1809-19.

[111] Graziani F, Tsakos G. Patient-based outcomes and quality of life. Periodontology. 2000; 2020: 277-94.

[112] Hajishengallis G, Lambris JD. Complement-targeted therapeutics in periodontitis. Adv Exp Med Biol. 2013; 735: 197-206.

[113] Barkats M, Bilang-Bleuel A, Buc-Caron M, Castel-Barthe M, Corti O, Finiels F, et al. Adenovirus in the brain: recent advances of gene therapy for neurodegenerative diseases. Prog Neurobiol. 1998; 55: 333-41.

[114] Radulova P, Slancheva B. Neonatal hypoxic-ischemic brain injury: pathogenesis and neuropathology. Akusherstvo i ginekologiia. 2014; 53: 41-7.

[115] Cardone M. Prospects for gene therapy in inherited neurodegenerative diseases. Curr Opin Neurol. 2007; 20: 151-8.

[116] Sudhakar V, Richardson R. Gene Therapy for Neurodegenerative Diseases. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2019; 16: 166-75.

[117] Li R, Liu Z, Pan Y, Chen L, Zhang Z, Lu L. Peripheral nerve injuries treatment: a systematic review. Cell Biochem Biophys. 2014; 68: 449-54.

[118] Cui C, Wang P, Cui N, Song S, Liang H, Ji A. Stichopus japonicus Polysaccharide, Fucoidan, or Heparin Enhanced the SDF-1α/CXCR4 Axis and Promoted NSC Migration via Activation of the PI3K/Akt/FOXO3a Signaling Pathway. Cell Mol Neurobiol. 2016; 36: 1311-29.

[119] Jinnou H, Sawada M, Kawase K, Kaneko N, Herranz-Pérez V, Miyamoto T, et al. Radial Glial Fibers Promote Neuronal Migration and Functional Recovery after Neonatal Brain Injury. Cell Stem Cell. 2018; 22: 128-37.e9.

[120] Saha B, Peron S, Murray K, Jaber M, Gaillard A. Cortical lesion stimulates adult subventricular zone neural progenitor cell proliferation and migration to the site of injury. Stem Cell Res. 2013; 11: 965-77.

[121] Giusto E, Donegà M, Cossetti C, Pluchino S. Neuro-immune interactions of neural stem cell transplants: from animal disease models to human trials. Exp Neurol. 2014; 260: 19-32.

[122] Marsal J, Agace W. Targeting T-cell migration in inflammatory bowel disease. J Intern Med. 2012; 272: 411-29.

[123] Nakatomi H, Kuriu T, Okabe S, Yamamoto S, Hatano O, Kawahara N, et al. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell. 2002; 110: 429-41.

[124] Forman M, Trojanowski J, Lee V. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med. 2004; 10: 1055-63.

[125] He Y, Pan S, Xu M, He R, Huang W, Song P, et al. Adeno-associated virus 9-mediated Cdk5 inhibitory peptide reverses pathologic changes and behavioral deficits in the Alzheimer’s disease mouse model. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2017; 31: 3383-92.

[126] Lee H, Kim J, Sung J, Yun W, Kim D, Lee H, et al. Asparagus cochinchinensis stimulates release of nerve growth factor and abrogates oxidative stress in the Tg2576 model for Alzheimer’s disease. BMC Complement Altern Med. 2018; 18: 125.

[127] Sorrentino V, Romani M, Mouchiroud L, Beck J, Zhang H, D’Amico D, et al. Enhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity. Nature. 2017; 552: 187-93.

[128] Ray A, Speese S, Logan M. Drosophila Glial Draper Rescues Aβ Toxicity in a Model of Alzheimer’s Disease. J Neurosci. 2017; 37: 11881-93.

[129] Lysen T, Darweesh S, Ikram M, Luik A, Ikram M. Sleep and risk of parkinsonism and Parkinson’s disease: a population-based study. Brain : a journal of neurology. 2019; 142: 2013-22.